ABSTRACT
Type 2 diabetes mellitus (T2D) is becoming increasingly prevalent worldwide and complications of T2D cause significant systemic and dental morbidity in the susceptible individual. Although T2D has been linked as a significant risk factor for chronic periodontitis (CP), molecular mechanisms explaining the pathogenesis and inflammatory impact of CP in T2D are lacking. iPLA2 is the calcium-independent form of phospholipase A2. In previous studies, we demonstrated that iPLA2 enzyme activity is altered in T2D. The purpose of this study was to elucidate the level of the iPLA2 abnormality in T2D by measuring messenger RNA levels in T2D-associated CP. A total of 53 healthy and T2D subjects with CP were recruited for this study. The clinical periodontal exam included probing pocket depth, clinical attachment levels and bleeding on probing. Peripheral venous blood was collected and neutrophils were isolated. Real time polymerase chain reaction was used to quantify iPLA2 mRNA in neutrophils from healthy controls and people with diabetes. Results revealed that the prevalence of moderate to severe CP was increased in people with T2D. The iPLA, mRNA levels in diabetics with different severity of CP were not significantly different compared to healthy controls; 1.07 vs 0.97 (mild CP), 1.07 vs 0.85 (moderate CP) and 1.07 vs 1.05 (severe CP). Collectively, the data suggest that levels of iPLA2 mRNA in T2D are not different than in health and are not directly influenced by periodontal disease status. The impact of inflammation on iPLA2 regulation is at the level of activation of the enzyme rather than expression at the mRNA level.
Subject(s)
Chronic Periodontitis/enzymology , Diabetes Mellitus, Type 2/enzymology , Group VI Phospholipases A2/analysis , Neutrophils/enzymology , RNA, Messenger/analysis , Adult , Case-Control Studies , Chronic Periodontitis/blood , Chronic Periodontitis/classification , Cohort Studies , Diabetes Mellitus, Type 2/blood , Enzyme Activation , Female , Gingival Hemorrhage/classification , Gingival Hemorrhage/enzymology , Group VI Phospholipases A2/genetics , Humans , Male , Periodontal Attachment Loss/classification , Periodontal Attachment Loss/enzymology , Periodontal Pocket/classification , Periodontal Pocket/enzymology , Real-Time Polymerase Chain Reaction/methodsABSTRACT
AIM: Following toll-like receptor (TLR) engagement, lipopolysaccharide (LPS) can stimulate the expression of pro-inflammatory cytokines thus activating the innate immune response. The production of inflammatory cytokines results, in part, from the activation of kinase-induced signalling cascades and transcriptional factors. Of the four distinct classes of mitogen-activated protein kinases (MAPK) described in mammals, p38, c-Jun N-terminal activated kinases (JNK1-3) and extracellular activated kinases (ERK1,2) are the best studied. Previous data have established that p38 MAPK signalling is required for inflammation and bone loss in periodontal disease pre-clinical animal models. MATERIALS & METHODS: In this study, we obtained healthy and diseased periodontal tissues along with clinical parameters and microbiological parameters. Excised fixed tissues were immunostained with total and phospho-specific antibodies against p38, JNK and ERK kinases. RESULTS: Intensity scoring from immunostained tissues was correlated with clinical periodontal parameters. Rank correlations with clinical indices were statistically significantly positive (p-value < 0.05) for total p38 (correlations ranging 0.49-0.68), phospho-p38 (range 0.44-0.56), and total ERK (range 0.52-0.59) levels, and correlations with JNK levels also supported association (range 0.42-0.59). Phospho-JNK and phospho-ERK showed no significant positive correlation with clinical parameters of disease. CONCLUSION: These data strongly implicate p38 MAPK as a major MAPK involved in human periodontal inflammation and severity.
Subject(s)
Chronic Periodontitis/enzymology , Mitogen-Activated Protein Kinases/analysis , Bacteroides/isolation & purification , Chronic Periodontitis/immunology , Chronic Periodontitis/microbiology , Dental Plaque Index , Female , Gingival Hemorrhage/enzymology , Gingival Hemorrhage/immunology , Gingival Hemorrhage/microbiology , Gingival Recession/enzymology , Gingival Recession/immunology , Gingival Recession/microbiology , Humans , Lymphocytes/immunology , Macrophages/immunology , Male , Mitogen-Activated Protein Kinase 1/analysis , Mitogen-Activated Protein Kinase 10/analysis , Mitogen-Activated Protein Kinase 3/analysis , Mitogen-Activated Protein Kinase 8/analysis , Mitogen-Activated Protein Kinase 9/analysis , Periodontal Attachment Loss/enzymology , Periodontal Attachment Loss/immunology , Periodontal Attachment Loss/microbiology , Periodontal Index , Periodontal Pocket/enzymology , Periodontal Pocket/immunology , Periodontal Pocket/microbiology , Periodontium/enzymology , Plasma Cells/immunology , Porphyromonas gingivalis/isolation & purification , Treponema denticola/isolation & purification , p38 Mitogen-Activated Protein Kinases/analysisABSTRACT
BACKGROUND AND OBJECTIVE: Periodontitis is more frequently found in subjects with Down's syndrome. The aim was to investigate whether the relationship between MMPs and TIMPs) in the gingival crevicular fluid of subjects with Down's syndrome is altered compared with controls. MATERIAL AND METHODS: Twenty-one adolescents with Down's syndrome and gingivitis (DS-G), 12 subjects with Down's syndrome and periodontitis (DS-P), 26 controls with gingivitis (HC-G) and eight controls with periodontitis (HC-P) were clinically examined. All patients were between 11 and 20 years of age. Gingival crevicular fluid was collected from each subject and the concentrations of MMPs (2, 3, 8, 9 and 13) and TIMPs (1, 2 and 3) (expressed as pg/µL adjusted for volume of gingival crevicular fluid) were determined using multianalyte kits from R&D Systems. RESULTS: The concentrations of MMP-2, MMP-3, MMP-8, MMP-9 and TIMP-2 in gingival crevicular fluid were significantly higher (p < 0.005) in the DS-G group compared with the HC-G group. The correlation coefficient between MMP-8 and TIMP-2 differed significantly (p = 0.006) between the DS-G group and the HC-G group. On the contrary, the correlation coefficients between MMPs and TIMPs did not differ significantly between the DS-P group and the HC-P group. However, the DS-P group exhibited a significantly lower concentration of TIMP-2 in the gingival crevicular fluid compared with the HC-P group. CONCLUSION: Down's syndrome subjects with gingivitis exhibit higher concentrations of MMPs in gingival crevicular fluid with an altered relationship between MMP-8 and TIMP-2, which might impair the periodontal tissue turnover.
Subject(s)
Down Syndrome/metabolism , Gingival Crevicular Fluid/chemistry , Matrix Metalloproteinase 8/analysis , Tissue Inhibitor of Metalloproteinase-2/analysis , Adolescent , Alveolar Bone Loss/enzymology , Alveolar Bone Loss/metabolism , Child , Cross-Sectional Studies , Down Syndrome/enzymology , Female , Gingival Crevicular Fluid/enzymology , Gingival Hemorrhage/enzymology , Gingival Hemorrhage/metabolism , Gingivitis/enzymology , Gingivitis/metabolism , Humans , Male , Matrix Metalloproteinase 13/analysis , Matrix Metalloproteinase 2/analysis , Matrix Metalloproteinase 3/analysis , Matrix Metalloproteinase 9/analysis , Oral Hygiene , Periodontal Pocket/enzymology , Periodontal Pocket/metabolism , Periodontitis/enzymology , Periodontitis/metabolism , Tissue Inhibitor of Metalloproteinase-1/analysis , Tissue Inhibitor of Metalloproteinase-3/analysis , Young AdultABSTRACT
BACKGROUND AND OBJECTIVE: Endopeptidases, such as neutral endopeptidase (NEP), endothelin-converting enzyme-1 (ECE-1) and a disintegrin and metalloprotease 17 (ADAM17), are believed to have various important roles in oral mucosal and epidermal tissue for the regulation of defensive biological responses in the oral cavity, and their expression and activity are influenced by various factors, including oral diseases. However, knowledge concerning these endopeptidases in the oral cavity has been minimal until now. This study focused on three metalloendopeptidases - NEP, ECE-1 and ADAM17 - in the oral buccal mucosal epithelium of patients with periodontal diseases and investigated the relationship between their gene-expression levels and periodontal disease. MATERIAL AND METHODS: The levels of expression of NEP, ECE-1 and ADAM17 mRNAs in tissue samples collected from the oral buccal mucosal epithelium of 61 patients were investigated by relative quantification using real-time RT-PCR analysis. information on oral and systemic health was obtained from the clinical record of each patient. RESULTS: Among the three groups, classified based on the diagnosis of periodontal diseases (healthy/gingivitis, early periodontitis and moderate/advanced periodontitis), the relative expression level of NEP mRNA was significantly increased in the early periodontitis group and in the moderate/advanced periodontitis group compared with that in the healthy/gingivitis group. Moreover, the relative expression levels of ECE1 and ADAM17 mRNAs were significantly increased in the moderate/advanced periodontitis group compared with those in the healthy/gingivitis group. The correlation coefficients between the mean relative expression levels of NEP and ECE1 mRNAs, NEP and ADAM17 mRNAs, and ECE1 and ADAM17 mRNAs were r = 0.758, r = 0.707 and r = 0.934, respectively (p < 0.001). Furthermore, among the oral-related factors, there was a significant correlation between the number of sites with probing pocket depths of more than 4 mm and of more than 6 mm and the relative expression levels of NEP, ECE1 and ADAM17 mRNAs. In stepwise logistic regression models, high relative expression levels of ECE1 and ADAM17 mRNAs were significantly associated with moderate/advanced periodontitis. CONCLUSION: The present study suggests that the severity of periodontal disease may be associated with the expression of metalloendopeptidase genes, including NEP, ECE1 and ADAM17, in the buccal mucosal epithelium.
Subject(s)
Metalloendopeptidases/genetics , Mouth Mucosa/enzymology , Periodontitis/enzymology , ADAM Proteins/genetics , ADAM17 Protein , Aged , Alveolar Bone Loss/enzymology , Alveolar Bone Loss/genetics , Aspartic Acid Endopeptidases/genetics , Chronic Periodontitis/enzymology , Chronic Periodontitis/genetics , Endothelin-Converting Enzymes , Epithelium/enzymology , Female , Gene Expression Regulation, Enzymologic/genetics , Gingival Hemorrhage/enzymology , Gingival Hemorrhage/genetics , Gingivitis/enzymology , Gingivitis/genetics , Humans , Male , Middle Aged , Neprilysin/genetics , Periodontal Pocket/enzymology , Periodontal Pocket/genetics , Periodontitis/genetics , Periodontium/enzymology , Real-Time Polymerase Chain Reaction/methods , Reverse Transcriptase Polymerase Chain Reaction/methods , Tumor Necrosis Factor-alpha/genetics , Young AdultABSTRACT
The aim of this study was to assess the presence of aspartate aminotransferase (AST) in peri-implant crevicular fluid, with or without clinical signs of mucositis, to determine its predictive diagnostic value, sensitivity, and specificity. The AST levels were determined (at a threshold of 1200 µIU/mL) for 60 clinically successful implants in 25 patients with or without peri-implant mucositis. Samples were taken prior (AST1) to peri-implant probing with a manual constant-pressure probe (0.2 N) and 15 minutes after probing (AST2). Clinical assessments included radiographic determination of preexisting bone loss, probing, and the evaluation of mucositis, plaque, and bleeding upon probing. Analysis was performed at both the level of the implant and the patient as a unit. We detected a significant difference between AST1 and AST2 at both levels. A significant difference was observed at AST1 between implants that bled upon probing and those that did not. However, when we considered the patient as a unit, there were no significant differences. The plaque index was not significant at either level. AST1 had high specificity and positive predictive diagnostic value (80%) for bleeding upon probing. Probing induces a greater release of AST from inflamed tissues compared with healthy tissues in situ but not at the systemic level. At the implant level, the implant position could be responsible for this difference. Aspartate aminotransferase was a reliable predictor of patients with mucositis.
Subject(s)
Aspartate Aminotransferases/analysis , Dental Implants , Gingival Crevicular Fluid/enzymology , Stomatitis/enzymology , Adolescent , Adult , Aged , Alveolar Bone Loss/enzymology , Dental Plaque Index , Female , Gingival Hemorrhage/enzymology , Humans , Male , Middle Aged , Osseointegration/physiology , Periodontal Index , Periodontal Pocket/enzymology , Predictive Value of Tests , Radiography, Bitewing , Sensitivity and Specificity , Young AdultABSTRACT
BACKGROUND AND OBJECTIVE: MMP-8 in gingival crevicular fluid is considered as a protease with high destructive potential because of its ability to degrade collagen in periodontitis-affected patients. The aim of this study was to investigate whether there was a relationship between clinical diagnostic parameters and the concentration of active MMP-8 (aMMP-8) in gingival crevicular fluid in a site-level full-mouth analysis. Based on these data, the prognostic value of aMMP-8 levels in relation to pocket depth may be evaluated. MATERIAL AND METHODS: Clinical measurements of pocket depth, bleeding on probing (BOP), plaque index (PlI) and gingival index (GI), as well as samples of gingival crevicular fluid, were obtained from four sites of each tooth of nine healthy female patients with chronic generalized periodontitis. The aMMP-8 concentration in gingival crevicular fluid was quantified by ELISA using specific monoclonal antibodies. Multiple linear regression models for the single measures of aMMP-8 and pocket depth were calculated with GI and BOP as additional variables. RESULTS: Between 92 and 112 recordings were obtained for each parameter in each patient. Mean values of between 31.5 and 88.8% were calculated for pocket depths of ≥ 4 mm. Mean pocket depths ranged from 3.11 to 4.73 mm, the mean BOP values ranged from 34.0 to 96.7% and the mean full-mouth gingival crevicular fluid aMMP-8 concentration ranged from 3.2 to 23.7 ng/mL. CONCLUSION: In this sample of female periodontitis patients, a broad range of intra-individual and interindividual aMMP-8 values was found. Although the explained variance was rather weak, a statistically significant relationship between aMMP-8 and pocket depth was proven.
Subject(s)
Chronic Periodontitis/enzymology , Gingival Crevicular Fluid/enzymology , Matrix Metalloproteinase 8/analysis , Adult , Aged , Biomarkers/analysis , Chronic Periodontitis/classification , Cross-Sectional Studies , Dental Plaque Index , Female , Gingival Hemorrhage/classification , Gingival Hemorrhage/enzymology , Humans , Linear Models , Middle Aged , Periodontal Index , Periodontal Pocket/classification , Periodontal Pocket/enzymologyABSTRACT
BACKGROUND AND OBJECTIVE: Our previous study showed that protease inhibitors were attenuated by the periodontal pathogen Porphyromonas gingivalis in cultured gingival epithelial cells. We hypothesize that fewer protease inhibitors would be present in more advanced periodontal disease sites, where the level of P. gingivalis may be high. The goal of this study was to investigate the relationship between the protease inhibitor [secretory leukocyte protease inhibitor (SLPI), elastase-specific inhibitor (ELAFIN) and squamous cell carcinoma antigen (SCCA)] levels in gingival crevicular fluid and the number of P. gingivalis micro-organisms in subgingival plaque. MATERIAL AND METHODS: Plaque samples from subjects without (n = 18) and with moderate to advanced periodontitis (n = 41) were used to quantify P. gingivalis using real-time PCR. Protease inhibitor levels in the gingival crevicular fluid of all the subjects were determined by ELISA. RESULTS: P. gingivalis was detected in 68.3% of patients with periodontitis, while 16.7% of subjects without periodontitis had a detectable level of P. gingivalis. Patients with periodontitis and P. gingivalis in their plaque exhibited lower SLPI and ELAFIN levels (p < 0.001) compared with control subjects without periodontitis. Secretory leukocyte protease inhibitor was also reduced (p < 0.05) in gingival crevicular fluid of periodontitis patients without a detectable level of P. gingivalis. Periodontitis patients with high vs. low levels of P. gingivalis exhibited reciprocal mean levels of SLPI and ELAFIN concentrations. CONCLUSION: The reduced concentrations of SLPI and ELAFIN may contribute to the loss of host protective capacity and increase susceptibility to breakdown from chronic infection. The work of this investigation may aid in finding diagnostic and prognostic markers in periodontal health and disease and may also help in finding pharmacological targets directed against periodontal inflammation.
Subject(s)
Chronic Periodontitis/enzymology , Periodontium/enzymology , Protease Inhibitors/analysis , Adult , Antigens, Neoplasm/analysis , Bacterial Load , Chronic Periodontitis/microbiology , Dental Plaque/microbiology , Dental Plaque Index , Elafin/analysis , Female , Gingival Crevicular Fluid/enzymology , Gingival Hemorrhage/enzymology , Gingival Hemorrhage/microbiology , Humans , Male , Middle Aged , Periodontal Attachment Loss/enzymology , Periodontal Attachment Loss/microbiology , Periodontal Index , Periodontal Pocket/enzymology , Periodontal Pocket/microbiology , Porphyromonas gingivalis/growth & development , Secretory Leukocyte Peptidase Inhibitor/analysis , Serpins/analysisABSTRACT
BACKGROUND: Cathepsin-K is an enzyme involved in bone metabolism which may make this feature important for both natural teeth and dental implants. The aims of the present study are to comparatively analyze the gingival crevicular fluid (GCF)/peri-implant sulcus fluid (PISF) cathepsin-K levels of natural teeth and dental implants, and to assess the potential relationship between this biochemical parameter and alveolar bone loss around natural teeth and dental implants. METHODS: Probing depth, bleeding on probing, gingival index, and plaque index clinical parameters were assessed, and GCF/PISF samples were obtained from natural teeth/dental implants presenting with either clinical health, gingivitis/peri-implant mucositis, or chronic periodontitis/peri-implantitis. Cathepsin-K activity levels of 42 GCF samples and 54 PISF samples were determined, and marginal bone loss (MBL) measures were calculated from digitalized standardized intraoral periapical radiographs obtained from natural teeth and dental implants by using cemento-enamel junction and the actual distance between two consecutive threads of the dental implant as reference points for natural teeth and dental implants, respectively. RESULTS: Comparing the natural teeth group with dental implant group with regard to MBL measure, cathepsin-K activity, and GCF/PISF volume revealed no significant differences. In both natural teeth and dental implant groups, despite higher MBL measures, cathepsin-K activity, and GCF/PISF volumes with the presence of inflammation, it was the presence of alveolar bone loss that lead to significantly higher values for these parameters. CONCLUSION: We suggest cathepsin-K as a biochemical parameter for monitoring periodontal/peri-implant alveolar bone loss.
Subject(s)
Alveolar Bone Loss/enzymology , Cathepsin K/analysis , Dental Implants , Gingival Crevicular Fluid/enzymology , Tooth/enzymology , Adult , Aged , Alveolar Bone Loss/diagnostic imaging , Biomarkers/analysis , Chronic Periodontitis/enzymology , Dental Plaque Index , Female , Gingival Hemorrhage/enzymology , Gingivitis/enzymology , Humans , Male , Middle Aged , Peri-Implantitis/enzymology , Periodontal Index , Periodontal Pocket/enzymology , Radiography, Bitewing , Stomatitis/enzymology , Young AdultABSTRACT
BACKGROUND AND OBJECTIVE: There are indications that acute myocardial infarction (AMI) may have an effect on the oral environment, which is reflected in the expression of salivary and gingival proteinases. According to our knowledge, no studies have been carried out to investigate the effect of AMI on the activities of two major tissue-destructive serine protease and microbial effectors, elastase and cathepsin G, produced by oral fluid polymorphonuclear granulocytes (PMN). Therefore, we compared the activities of elastase and cathepsin G in saliva from patients with AMI and from systemically healthy subjects (non-AMI) with similar periodontal conditions. MATERIAL AND METHODS: A total of 92 patients (47 AMI and 28 non-AMI patients with gingivitis or periodontitis, and 17 systemically and periodontally healthy subjects as a control group) were recruited. Clinical periodontal measurements were recorded, and stimulated whole-saliva samples were collected. The patients with AMI were clinically examined within 3-4 d after admission to the coronary care unit. The activities of saliva neutrophil elastase and cathepsin G were measured after collection, at specific time-points during incubation (from baseline to 23 h) by specific synthetic peptide substrate assays. RESULTS: The saliva of patients with AMI and periodontitis had a significant trend for the highest elastase activities among the study groups. Elastase and cathepsin G activities correlated significantly with each other in the AMI periodontitis group (r = 0.8, p < 0.01). In a logistic regression analysis, the level of salivary elastase activity associated significantly with periodontitis. CONCLUSION: AMI may be reflected in PMN serine protease elastase activity in saliva, despite its strong association with periodontitis.
Subject(s)
Cathepsin G/analysis , Leukocyte Elastase/analysis , Myocardial Infarction/enzymology , Periodontitis/enzymology , Saliva/enzymology , Salivary Proteins and Peptides/analysis , Adult , Aged , Chronic Periodontitis/enzymology , Female , Follow-Up Studies , Gingival Hemorrhage/enzymology , Gingivitis/enzymology , Humans , Male , Middle Aged , Periodontal Pocket/enzymology , Tooth Loss/enzymologyABSTRACT
PURPOSE: Cathepsin-K is an enzyme involved in bone metabolism. This feature may make it important both for natural teeth and dental implants. The aims of the present study were to comparatively analyze cathepsin-K levels in gingival crevicular fluid (GCF) and peri-implant sulcus fluid (PISF) and to determine whether GCF and PISF cathepsin-K profiles reflect the clinical periodontal/peri-implant status. MATERIALS AND METHODS: Clinical parameters (probing depth, Gingival Index, Plaque Index, and bleeding on probing) were recorded, and GCF/PISF samples were obtained from natural teeth (group T) and dental implants (group I), which were divided into groups based on health (clinically healthy, gingivitis/peri-implant mucositis, and periodontitis/peri-implantitis). Cathepsin-K activity was determined with a commercially available cathepsin-K activity assay kit (BioVision). RESULTS: Sixty natural teeth and 68 dental implants were examined. Teeth with periodontitis (group T-3) showed significantly higher total cathepsin-K activity (10.39 units) than teeth with gingivitis (group T-2, 1.71 units) and healthy teeth (group T-1, 1.90 units). The difference in cathepsin-K activity between groups T-2 and T-1 was not significant. Implants with peri-implantitis (group I-3) had higher total enzyme activity (10.26 units) than healthy implants (group I-1) (3.44 units). Although the difference between clinical parameters was not significant, group I-3 had higher cathepsin-K levels than group I-2 (4.74 units). When natural teeth (T-1, T-2, T-3) were compared to implants (I-1, I-2, I-3), no significant differences were observed for cathepsin-K levels. CONCLUSION: More cathepsin-K activity was clearly observed with inflammatory periodontal and peri-implant destruction. The highest cathepsin-K levels detected in GCF and PISF samples, obtained from sites with periodontitis and peri-implantitis, suggests the potential involvement of cathespin-K in increased bone metabolism around natural teeth and dental implants.
Subject(s)
Cathepsin K/analysis , Dental Implants , Gingival Crevicular Fluid/enzymology , Periodontal Diseases/enzymology , Adult , Aged , Alveolar Bone Loss/classification , Alveolar Bone Loss/enzymology , Dental Plaque Index , Female , Gingiva/enzymology , Gingival Hemorrhage/classification , Gingival Hemorrhage/enzymology , Gingivitis/enzymology , Humans , Male , Middle Aged , Peri-Implantitis/enzymology , Periodontal Index , Periodontal Pocket/classification , Periodontal Pocket/enzymology , Periodontitis/enzymology , Periodontium/enzymology , Stomatitis/enzymology , Young AdultABSTRACT
BACKGROUND: The aim of this study is to investigate the impact of smoking status on the systemic and local superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and catalase (CAT) activities and malondialdehyde (MDA) levels in subjects with chronic periodontitis (CP). METHODS: Sixty-five CP patients (23 smokers [CP-S], 23 former smokers [CP-FS], and 19 non-smokers [CP-NS]) and 20 periodontally healthy non-smoker controls (PH-NS) were included in the study. After the clinical measurements, serum and gingival tissue samples were collected. SOD, GSH-Px, and CAT activities and MDA levels in hemolysates and gingival tissue samples were spectrophotometrically assayed. RESULTS: Blood MDA levels in all the periodontitis groups were higher than in the PH-NS group but only the difference between CP-FS and PH-NS groups was significant (P <0.01). Gingival tissue MDA levels in the periodontitis groups were significantly higher than that in the control group (P <0.01). However, the control group had the highest gingival SOD, GSH-Px, and CAT activities compared with all the periodontitis groups (P <0.01). The CP-S group had the highest gingival MDA levels and SOD, GSH-Px, and CAT activities among the periodontitis groups, whereas the lowest values were observed in the CP-NS group (P <0.01). The blood and gingival MDA levels in the CP-FS group were similar in the CP-NS group, whereas they were lower than in the CP-S group. CONCLUSIONS: Systemic and local MDA levels are increased by smoking in addition to the impact of periodontitis. The decreased local SOD, GSH-Px, and CAT activities observed in periodontitis patients may increase with smoking.
Subject(s)
Antioxidants/metabolism , Chronic Periodontitis/enzymology , Malondialdehyde/analysis , Smoking/metabolism , Adult , Antioxidants/analysis , Catalase/blood , Catalase/metabolism , Chronic Periodontitis/blood , Dental Plaque Index , Female , Free Radical Scavengers/blood , Free Radical Scavengers/metabolism , Gingiva/enzymology , Gingiva/metabolism , Gingival Hemorrhage/blood , Gingival Hemorrhage/enzymology , Glutathione Peroxidase/blood , Glutathione Peroxidase/metabolism , Humans , Male , Malondialdehyde/blood , Middle Aged , Periodontal Attachment Loss/blood , Periodontal Attachment Loss/enzymology , Periodontal Index , Periodontal Pocket/blood , Periodontal Pocket/enzymology , Smoking/blood , Spectrophotometry , Superoxide Dismutase/blood , Superoxide Dismutase/metabolism , Young AdultABSTRACT
BACKGROUND: The potential of alkaline phosphatase (ALP) as an important diagnostic marker of gingival crevicular fluid (GCF) has been the subject to investigation since 1970. ALP is stored in specific granules and secretory vesicles of the neutrophils and is mainly released during their migration to the site of infection. It is also present in bacteria within dental plaque, osteoblasts and fibroblasts. It has, thus, become important to elucidate whether GCF levels of ALP are potential measures of the inflammatory activity occurring in the adjacent periodontal tissues. OBJECTIVE: The aim of this study was to assess the total activity of ALP in the GCF collected from healthy sites, sites with gingivitis and with chronic adult periodontitis. An attempt was also made to establish the correlation of ALP activity with plaque index, gingival index, bleeding index and probing depth. MATERIALS AND METHODS: A total of 18 patients were divided into three groups: viz., healthy sites, Group I; gingivitis, Group II; chronic periodontitis, Group III. Clinical parameters like plaque index, bleeding index, gingival index and probing depth were recorded. The ALP level in GCF of all three groups was determined by spectrophotometric analysis. RESULTS: Total enzyme activity of ALP was significantly higher in periodontitis as compared with that in healthy and gingivitis sites, and was significantly and positively correlated with probing depth. CONCLUSION: ALP can be considered as a periodontal disease marker as it can distinguish between healthy and inflamed sites. However, to better define its capacity for periodontal diagnosis, additional longitudinal studies are required.
Subject(s)
Alkaline Phosphatase/analysis , Gingival Crevicular Fluid/enzymology , Periodontal Diseases/enzymology , Adult , Alveolar Bone Loss/enzymology , Biomarkers/analysis , Chronic Periodontitis/enzymology , Dental Plaque Index , Female , Gingiva/enzymology , Gingival Hemorrhage/enzymology , Gingivitis/enzymology , Humans , Male , Middle Aged , Periodontal Index , Periodontal Pocket/enzymology , Spectrophotometry , Young AdultABSTRACT
BACKGROUND: Pregnancy induces or enhances susceptibility to gingivitis; however, the presence and role of neutrophilic enzymes in pregnancy-related gingivitis are not well known. The present study demonstrates the relationship between neutrophilic enzymes in gingival crevicular fluid (GCF) and periodontal status during pregnancy and postpartum. METHODS: At baseline, 30 periodontally healthy pregnant women (Pr group) and 24 non-pregnant women (N-Pr group) as their controls participated in the study. The Pr group was examined once per each trimester and twice during postpartum and the N-Pr group three times (on successive months). During each visit, GCF samples were collected from all first molars, and clinical measurements (visible plaque index, bleeding on probing [BOP], probing depth [PD], and clinical attachment level) were recorded. The samples were analyzed for matrix metalloproteinase (MMP)-8, polymorphonuclear neutrophil (PMN) elastase, myeloperoxidase (MPO), and tissue inhibitor of matrix metalloproteinase (TIMP)-1. Their levels were compared to the periodontal status at the collection site. RESULTS: In the Pr group, BOP and PD scores significantly increased between the first and second trimester, indicating pregnancy gingivitis. This increased inflammation was not reflected by the enzymes examined in GCF; the amounts of PMN elastase decreased continuously during the follow-up period, and those of MPO and MMP-8 did not increase until delivery, whereas TIMP-1 amounts remained stable throughout the follow-up period. In the N-Pr group, all parameters remained steady. CONCLUSION: Despite an increased susceptibility to gingivitis during mid-pregnancy, the host response does not seem to activate its own degradative enzymes.
Subject(s)
Gingival Crevicular Fluid/enzymology , Neutrophils/enzymology , Periodontal Index , Postpartum Period/metabolism , Pregnancy/metabolism , Adult , Cohort Studies , Dental Plaque Index , Female , Follow-Up Studies , Gingival Hemorrhage/classification , Gingival Hemorrhage/enzymology , Gingivitis/classification , Gingivitis/enzymology , Humans , Leukocyte Elastase/analysis , Longitudinal Studies , Matrix Metalloproteinase 8/analysis , Periodontal Attachment Loss/classification , Periodontal Attachment Loss/enzymology , Periodontal Pocket/classification , Periodontal Pocket/enzymology , Peroxidase/analysis , Pregnancy Complications/classification , Pregnancy Complications/enzymology , Pregnancy Trimesters/metabolism , Tissue Inhibitor of Metalloproteinase-1/analysis , Young AdultABSTRACT
BACKGROUND AND OBJECTIVE: Matrix metalloproteinases (MMPs) and their regulators are connected to periodontal inflammation and destruction. However, the presence and role of the salivary MMPs in pregnancy-related gingivitis are not well known. Our longitudinal study aimed to monitor salivary proteinase levels and possible changes, and relate them to periodontal status during pregnancy and postpartum. MATERIAL AND METHODS: Salivary samples were collected from 30 periodontally healthy pregnant women five times (once during each trimester, 4-6 wk after delivery and after lactation) and, as their controls, from 24 non-pregnant women three times (during successive months). Periodontal examination included visible plaque index, bleeding on probing, probing pocket depth and clinical attachment level measurements. Matrix metalloproteinase-8 levels were measured by immunofluorometric assay, and MMP-2 and MMP-9 levels and molecular forms by gelatin zymography. Salivary elastase, myeloperoxidase and tissue inhibitor of matrix metalloproteinase-1 levels were measured by ELISA. RESULTS: Elastase concentrations maintained stable during the follow-up, while myeloperoxidase concentrations increased significantly after delivery. During pregnancy, MMP-8 concentrations were significantly lower than postpartum concentrations, being lowest during the second trimester and highest after delivery, and varying inversely to pregnancy gingivitis, observed as elevated percentages of bleeding on probing and probing pocket depth during the second and third trimester. In pregnant women, the highest MMP-2 and MMP-9 levels were found in saliva after lactation. In the control group, both clinical and enzymological findings remained stable during the follow-up period. CONCLUSION: Our results suggest that hormonal changes during pregnancy induce or enhance susceptibility to gingivitis, while salivary proteinase and myeloperoxidase levels are reduced.
Subject(s)
Peptide Hydrolases/analysis , Postpartum Period/metabolism , Salivary Proteins and Peptides/analysis , Adult , Dental Plaque Index , Female , Follow-Up Studies , Gingival Hemorrhage/classification , Gingival Hemorrhage/enzymology , Gingivitis/enzymology , Humans , Lactation/metabolism , Longitudinal Studies , Matrix Metalloproteinase 2/analysis , Matrix Metalloproteinase 8/analysis , Matrix Metalloproteinase 9/analysis , Pancreatic Elastase/analysis , Periodontal Attachment Loss/classification , Periodontal Attachment Loss/enzymology , Periodontal Index , Periodontal Pocket/classification , Periodontal Pocket/enzymology , Peroxidase/analysis , Pregnancy , Pregnancy Complications/enzymology , Pregnancy Trimesters/metabolism , Tissue Inhibitor of Metalloproteinase-1/analysis , Young AdultABSTRACT
OBJECTIVES: To evaluate whether type 2 diabetes mellitus (DM) enlarged and if so the quantum of such increase in the gingival crevicular fluid (GCF) levels of matrix metalloproteinase-8 (MMP-8), MMP-13 and tissue inhibitor of metalloproteinases-1 (TIMP-1). METHODS: Subjects (n = 73) were divided into five groups as follows: 12 DM patients with gingivitis (DM-G), 12 DM patients with periodontitis (DM-P), 12 systemically healthy patients with gingivitis (H-G), 13 systemically healthy patients with periodontitis (H-P) and 24 periodontally, systemically healthy volunteer subjects (H-C). Full-mouth clinical periodontal measurements were performed at six sites per tooth. Gingival crevicular fluid samples were obtained from two sites representing the clinical periodontal diagnosis in single-rooted teeth. Gingival crevicular fluid levels of MMP-8, MMP-13 and TIMP-1 were analysed by immunofluorometric MMP assay (IFMA), enzyme-linked immunosorbent assay (ELISA). Data were tested statistically by parametric tests. RESULTS: All clinical periodontal measurements were similar in both diabetic and systemically healthy patients with periodontal disease (all P > 0.05). Total amounts of MMP-8 in GCF samples were significantly lower in H-C group than DM-G, DM-P, H-P groups (all P < 0.05). Matrix metalloproteinase-13, TIMP-1 total amounts were similar in study groups (P > 0.05). Diabetes mellitus patients exhibited similar levels of MMP-8, MMP-13, TIMP-1 with systemically healthy gingivitis/periodontitis patients (P > 0.05). CONCLUSIONS: Within the limits of this study, DM does not seem to significantly affect GCF levels of MMP-8, MMP-13, TIMP-1 or clinical periodontal status.
Subject(s)
Diabetes Mellitus, Type 2/enzymology , Gingival Crevicular Fluid/enzymology , Matrix Metalloproteinase 13/analysis , Matrix Metalloproteinase 8/analysis , Tissue Inhibitor of Metalloproteinase-1/analysis , Blood Glucose/analysis , Body Mass Index , Case-Control Studies , Cholesterol/blood , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Chronic Periodontitis/complications , Chronic Periodontitis/enzymology , Cross-Sectional Studies , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/complications , Female , Gingival Hemorrhage/complications , Gingival Hemorrhage/enzymology , Gingivitis/complications , Gingivitis/enzymology , Glycated Hemoglobin/analysis , Humans , Male , Middle Aged , Periodontal Attachment Loss/complications , Periodontal Attachment Loss/enzymology , Periodontal Pocket/complications , Periodontal Pocket/enzymology , Smoking , Time Factors , Triglycerides/bloodABSTRACT
BACKGROUND AND OBJECTIVE: High levels of colonization by periodontopathic bacteria and a high prevalence of chronic inflammatory periodontal disease have been reported in children with Down's syndrome. Matrix metalloproteinases (MMPs) are mediators of extracellular matrix degradation and remodelling, and are deeply involved in the course of periodontal disease. To clarify the relationship between Down's syndrome and periodontitis, we investigated levels of MMP-2 and MMP-8 in gingival crevicular fluid (GCF) and detection of periodontopathic bacteria from subgingival plaque. MATERIAL AND METHODS: Samples of GCF and plaque were isolated from central incisors. Levels of MMPs were evaluated by enzyme-linked immunosorbent assay, and periodontopathic bacteria were detected by polymerase chain reaction. RESULTS: Levels of MMP-2 and MMP-8 in Down's syndrome patients were higher than those in healthy control subjects. In the Down's syndrome group, increases in these MMPs were observed in GCF from patients with an oral hygiene index score of < 2 and in GCF from sites that were negative for bleeding on probing. The detection rate of periodontopathic bacteria in Down's syndrome patients was higher than that in the control subjects. Matrix metalloproteinase-2 levels in sites harbouring Porphyromonas gingivalis or Aggregatibacter (Actinobacillus) actinomycetemcomitans were lower than in those without these microorganisms. CONCLUSION: These results suggest an increase in MMP-2 and MMP-8 in Down's syndrome patients, regardless of whether inflammation of periodontal tissue is present or not.
Subject(s)
Down Syndrome/enzymology , Gingival Crevicular Fluid/enzymology , Matrix Metalloproteinase 2/analysis , Matrix Metalloproteinase 8/analysis , Adolescent , Aggregatibacter actinomycetemcomitans/isolation & purification , Campylobacter rectus/isolation & purification , Child , Colony Count, Microbial , Dental Plaque/microbiology , Female , Gingiva/enzymology , Gingival Hemorrhage/classification , Gingival Hemorrhage/enzymology , Gingival Pocket/classification , Gingival Pocket/enzymology , Humans , Male , Oral Hygiene Index , Periodontal Index , Periodontal Pocket/classification , Periodontal Pocket/enzymology , Porphyromonas gingivalis/isolation & purificationABSTRACT
BACKGROUND: Alanine aminopeptidase (ALAP) and dipeptidyl peptidase IV (DPPIV) are ectopeptidases that play a role in collagen degradation and are thought to be involved in the destruction of periodontal tissue. This study compared the activities of salivary ALAP and DPPIV in patients with periodontitis and periodontally healthy subjects. The correlations of enzyme activities with clinical variables and the presence of Porphyromonas gingivalis were also evaluated. METHODS: Whole saliva was collected from 30 periodontally healthy subjects, 30 localized chronic periodontitis (LCP) patients, and 30 generalized chronic periodontitis (GCP) patients to determine the activities of ALAP and DPPIV. The presence of P. gingivalis in subgingival plaque was detected by polymerase chain reaction. Periodontal clinical assessments included probing depth, clinical attachment level, and bleeding on probing. RESULTS: The activities of DPPIV in the LCP and GCP groups were not significantly different from one another, but both groups had significantly higher enzyme activities than the periodontally healthy group (P = 0.001). DPPIV activity was positively correlated with all clinical parameters and the prevalence of P. gingivalis. The ALAP activities were not significantly different among the three study groups. There was no significant correlation of ALAP activity with any of the clinical and bacterial parameters. CONCLUSION: DPPIV, but not ALAP, activity is associated with periodontitis and the presence of P. gingivalis.
Subject(s)
CD13 Antigens/analysis , Chronic Periodontitis/enzymology , Dipeptidyl Peptidase 4/analysis , Saliva/enzymology , Salivary Proteins and Peptides/analysis , Adult , Age Factors , Aged , Chronic Periodontitis/microbiology , Colony Count, Microbial , Dental Plaque/microbiology , Female , Gingival Hemorrhage/enzymology , Gingival Hemorrhage/microbiology , Humans , Male , Middle Aged , Periodontal Attachment Loss/enzymology , Periodontal Attachment Loss/microbiology , Periodontal Pocket/enzymology , Periodontal Pocket/microbiology , Periodontium/enzymology , Porphyromonas gingivalis/physiology , Sex Factors , Young AdultABSTRACT
PURPOSE: Assessment of the effect of treatment with aprotinin-containing drug on the clinical status of the periodontal tissue and on the concentrations of metalloproteinases released in the course of periodontitis (MMP-1, MMP-2) as well as their tissue inhibitors (TIMP-1 and TIMP-2) in the saliva of patients with chronic periodontitis (CP). MATERIAL/METHODS: The study involved 25 subjects with CP (39-68 years), including 16 women and 9 men. The patients were prescribed aprotinin preparation to be taken for 2 weeks. The control group (C) involved 14 healthy subjects (41-65 years), including 10 women and 4 men. Two periodontal indices were assessed: the approximal plaque index (API) and bleeding on probing index (BOP). Periodontal pocket depth and clinical attachment level were also evaluated. The concentrations of MMP-1 and MMP-2 as well as TIMP-1 and TIMP-2 were determined by the ELISA method. RESULTS: The mean salivary MMP-1 concentration in patients with CP was significantly higher before and after treatment, as compared to healthy subjects. The mean salivary MMP-2 concentration in CP patients at baseline was also higher as compared to the C group and increased after treatment. The mean salivary TIMP-1 and TIMP-2 concentration in CP patients was higher as compared to C group and increased after treatment. CONCLUSIONS: Since the mean MMPs levels were found to be growing it can be assumed that aprotinin has no significant effect on the regulation of MMPs in the saliva of CP patients. It thus seems that aprotinin application after scaling has no additional therapeutic effect.
Subject(s)
Aprotinin/therapeutic use , Chronic Periodontitis/drug therapy , Matrix Metalloproteinase 1/analysis , Matrix Metalloproteinase 2/analysis , Periodontal Index , Saliva/enzymology , Serine Proteinase Inhibitors/therapeutic use , Tissue Inhibitor of Metalloproteinase-1/analysis , Tissue Inhibitor of Metalloproteinase-2/analysis , Adult , Aged , Chronic Periodontitis/enzymology , Dental Plaque Index , Dental Scaling , Female , Gingival Hemorrhage/drug therapy , Gingival Hemorrhage/enzymology , Humans , Male , Middle Aged , Periodontal Attachment Loss/drug therapy , Periodontal Attachment Loss/enzymology , Periodontal Pocket/drug therapy , Periodontal Pocket/enzymology , Periodontium/drug effects , Periodontium/enzymology , Root Planing , Saliva/drug effectsABSTRACT
BACKGROUND AND OBJECTIVE: Extracellular matrix metalloproteinase inducer (EMMPRIN), an immunoglobulin-like cell surface glycoprotein, could promote collagenolytic balance in favor of the expression and activation of matrix metalloproteinases (MMPs). This study was to investigate the expression of EMMPRIN in gingival tissues from different periodontal conditions and to correlate it with the production of MMP-1 and MMP-2. MATERIAL AND METHODS: Gingival biopsies were collected from 15 patients with untreated advanced chronic periodontitis and 15 patients with aggressive periodontitis (AgP). The control group consisted of 12 subjects diagnosed either as periodontally healthy individuals or as individuals with a gingival index of one (H/G1). The peptides and mRNA of EMMPRIN, MMP-1 and MMP-2 were detected by immunohistochemistry and semi-quantitative reverse transcriptase-polymerase chain reaction, respectively. RESULTS: The expression of EMMPRIN, MMP-1 and MMP-2 peptides in periodontally healthy tissues was mainly confined to the gingival epithelium. The EMMPRIN was strongly expressed in the cell membrane of the basal layer. Immunoreactivity for EMMPRIN was more intensive and more widespread in periodontitis, extended from the epithelial layers to the underlying connective tissues, and was essential in both inflammatory and fibroblast-like cells. In addition, MMP-1 and MMP-2 showed the same localized expression. The chronic periodontitis group had a significantly higher mRNA expression of EMMPRIN and MMP-2 compared with the H/G1 subjects (p < 0.05). Production of MMP-1 and MMP-2 by gingival tissues was correlated with the mRNA level of EMMPRIN (r = 0.463, p = 0.013 for MMP-1 and r = 0.404, p = 0.033 for MMP-2). CONCLUSION: The expression of EMMPRIN in human normal and diseased gingiva might contribute to periodontal physiological and pathological processes; moreover, its increased production might be associated with MMP-1 and MMP-2 expression.
Subject(s)
Basigin/analysis , Gingiva/enzymology , Matrix Metalloproteinase 1/analysis , Matrix Metalloproteinase 2/analysis , Periodontitis/enzymology , Adolescent , Adult , Aggressive Periodontitis/enzymology , Aggressive Periodontitis/pathology , Biopsy , Cell Membrane/enzymology , Cell Membrane/ultrastructure , Child , Chronic Periodontitis/enzymology , Chronic Periodontitis/pathology , Connective Tissue/enzymology , Connective Tissue/pathology , Dental Plaque Index , Epithelial Cells/enzymology , Epithelial Cells/ultrastructure , Epithelium/enzymology , Epithelium/pathology , Fibroblasts/enzymology , Fibroblasts/pathology , Gingiva/pathology , Gingival Hemorrhage/enzymology , Gingival Hemorrhage/pathology , Humans , Middle Aged , Periodontal Index , Periodontal Pocket/enzymology , Periodontal Pocket/pathology , Periodontitis/pathology , Young AdultABSTRACT
AIM: The aims of this study were to investigate (a) the matrix metalloproteinase-13 (MMP-13) promoter polymorphisms in severe, generalized chronic periodontitis (CP), (b) the relationship of periodontal therapy outcome with these genotypes and (c) gingival crevicular fluid (GCF) MMP-13 level-MMP-13 genotype correlation. MATERIALS AND METHODS: Genomic DNA was obtained from peripheral blood of 102 patients with severe, generalized CP, and 98 periodontally healthy subjects. MMP-13 -77A/G and 11A/12A polymorphisms were determined by the polymerase chain reaction-restriction fragment length polymorphism and DNA sequencing methods, respectively. Fifty-eight CP patients received non-surgical periodontal therapy and were followed for 6 months. Clinical periodontal parameters and GCF samples were collected at baseline and at 6 months. GCF MMP-13 levels were analysed by an enzyme-linked immunosorbent assay. RESULTS: The distribution of MMP-13 -77AG genotypes and allele frequencies did not differ significantly between study groups (p>0.05). Study subjects, except 3, had the 11A/11A genotype. MMP-13 -77G allele carriers had similar GCF MMP-13 levels and clinical periodontal parameters compared with AA genotypes after non-surgical periodontal therapy (p<0.05). CONCLUSIONS: These data suggest that the -77A/G and 11A/12A polymorphisms of MMP-13 gene are not associated with susceptibility to severe, generalized CP in a Turkish population. It seems that -77G allele carriage may not influence the outcome of periodontal therapy.